|
WO2008001076A1
(en)
|
2006-06-26 |
2008-01-03 |
Ucb Pharma S.A. |
Fused thiazole derivatives as kinase inhibitors
|
|
WO2009001089A1
(en)
*
|
2007-06-26 |
2008-12-31 |
Ucb Pharma S.A. |
Fused thiazole derivatives as kinase inhibitors
|
|
GB0620059D0
(en)
*
|
2006-10-10 |
2006-11-22 |
Ucb Sa |
Therapeutic agents
|
|
GB0620818D0
(en)
*
|
2006-10-19 |
2006-11-29 |
Ucb Sa |
Therapeutic agents
|
|
CA2669886A1
(en)
|
2006-11-15 |
2008-05-22 |
Vertex Pharmaceuticals Incorporated |
Compounds useful as protein kinase inhibitors
|
|
RU2478387C2
(ru)
|
2007-02-20 |
2013-04-10 |
Новартис Аг |
ИМИДАЗОХИНОЛИНЫ В КАЧЕСТВЕ ДВОЙНЫХ ИНГИБИТОРОВ ЛИПИДКИНАЗЫ И mTOR
|
|
ATE510841T1
(de)
|
2007-06-12 |
2011-06-15 |
Hoffmann La Roche |
Thiazoliopyrimidine und ihre verwendung als hemmer der phosphatidylinositol-3 kinase
|
|
WO2009036768A2
(en)
*
|
2007-09-19 |
2009-03-26 |
H. Lundbeck A/S |
Diagnosing potential weight gain in a subject
|
|
CN101932587A
(zh)
|
2007-09-24 |
2010-12-29 |
吉宁特有限公司 |
噻唑并嘧啶pi3k抑制剂化合物及使用方法
|
|
WO2009055730A1
(en)
|
2007-10-25 |
2009-04-30 |
Genentech, Inc. |
Process for making thienopyrimidine compounds
|
|
WO2009071895A1
(en)
*
|
2007-12-04 |
2009-06-11 |
Ucb Pharma S.A. |
Fused thiazole and thiophene derivatives as kinase inhibitors
|
|
WO2009071890A1
(en)
*
|
2007-12-04 |
2009-06-11 |
Ucb Pharma S.A. |
Tricyclic kinase inhibitors
|
|
GB0723747D0
(en)
*
|
2007-12-04 |
2008-12-31 |
Ucb Pharma Sa |
Therapeutic agents
|
|
WO2009094224A1
(en)
|
2008-01-25 |
2009-07-30 |
Millennium Pharmaceuticals, Inc. |
Thiophenes and their use as phosphatidylinositol 3-kinase (pi3k) inhibitors
|
|
WO2009120826A1
(en)
*
|
2008-03-27 |
2009-10-01 |
Wyeth |
2-aryl- and 2-heteroarylthiazolyl compounds, methods for their preparation and use thereof
|
|
GB0805818D0
(en)
*
|
2008-03-31 |
2008-04-30 |
Ucb Pharma Sa |
Therapeutic agents
|
|
US9090601B2
(en)
|
2009-01-30 |
2015-07-28 |
Millennium Pharmaceuticals, Inc. |
Thiazole derivatives
|
|
JP2012516329A
(ja)
|
2009-01-30 |
2012-07-19 |
ミレニアム ファーマシューティカルズ, インコーポレイテッド |
Pi3k阻害剤としてのヘテロアリールおよびその使用
|
|
US8796314B2
(en)
|
2009-01-30 |
2014-08-05 |
Millennium Pharmaceuticals, Inc. |
Heteroaryls and uses thereof
|
|
ES2638323T3
(es)
|
2009-05-20 |
2017-10-19 |
Glaxosmithkline Llc |
Derivados de tiazolopirimidinona como inhibidores de PI3 quinasa
|
|
SG182247A1
(en)
|
2009-05-27 |
2012-08-30 |
Hoffmann La Roche |
Bicyclic indole-pyrimidine pi3k inhibitor compounds selective for p110 delta, and methods of use
|
|
MX2011012520A
(es)
|
2009-05-27 |
2011-12-12 |
Hoffmann La Roche |
Compuestos inhibidores de pi3k de pirimidina biciclicos selectivos para p110 delta y metodos de uso de los mismos.
|
|
US9062038B2
(en)
|
2010-08-11 |
2015-06-23 |
Millennium Pharmaceuticals, Inc. |
Heteroaryls and uses thereof
|
|
US8859768B2
(en)
|
2010-08-11 |
2014-10-14 |
Millennium Pharmaceuticals, Inc. |
Heteroaryls and uses thereof
|
|
EP2603214A4
(en)
|
2010-08-11 |
2013-12-18 |
Millennium Pharm Inc |
HETEROARYLE AND USES THEREOF
|
|
MX2013004003A
(es)
*
|
2010-10-13 |
2013-10-01 |
Millenium Pharmaceuticals Inc |
Heteroarilos y usos de los mismos.
|
|
AU2012226375B2
(en)
|
2011-03-10 |
2017-04-13 |
Lupin Atlantis Holdings Sa |
Substituted morpholines as modulators for the calcium sensing receptor
|
|
TWI710558B
(zh)
|
2013-05-01 |
2020-11-21 |
瑞士商赫孚孟拉羅股份公司 |
二雜芳基化合物及其用途
|
|
US10722484B2
(en)
|
2016-03-09 |
2020-07-28 |
K-Gen, Inc. |
Methods of cancer treatment
|
|
CN107556199A
(zh)
*
|
2017-09-24 |
2018-01-09 |
杨子辉 |
一种3,4‑二氯‑2‑氨基‑5‑氟联苯的制备方法
|